PF-08046054 by Pfizer for Solid Tumor: Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Solid Tumor.

Stigmatizing Language Common on Liver Transplant Websites

Stigmatizing words like “alcoholic” and “alcoholism” are frequently used on the websites of liver transplant centers, and this language may discourage patients from seeking treatment,

February 9, 2024

MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTP

MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science &

September 18, 2023

Green Dragon founders fired up to “get back to where we were” with new joint – The Cannabist

The first dispensary chain founded by Alex Levine, Andy Levine and Lisa Leder is preparing to cease operations in Colorado, three years after they sold

November 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.